Overview

Description

  • NatureSynthetic

Associated products

Specifications

Our Abpromise guarantee covers the use of ab105631 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Purity70 - 90% by HPLC.

  • FormLiquid
  • Additional notes

    - First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
    - If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
    - Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
    - Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
    - Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

    Information available upon request.

General Info

  • Alternative names
    • CCM2
    • CDK4 inhibitor p16 INK4
    • CDK4I
    • CDKN2
    • CDKN2A
    • Cell cycle negative regulator beta
    • CMM2
    • Cyclin dependent kinase 4 inhibitor A
    • Cyclin Dependent Kinase Inhibitor 2A
    • Cyclin dependent kinase inhibitor 2A (melanoma p16 inhibits CDK4)
    • Cyclin dependent kinase inhibitor 2A isoform 4
    • Cyclin dependent kinase inhibitor 2A isoforms 1/2/3
    • Cyclin dependent kinase inhibitor p16
    • INK4
    • INK4A
    • MLM
    • MTS1
    • Multiple tumor suppressor 1
    • p14
    • p16
    • P16INK4
    • p16INK4a
    • p19
    • p19Arf
    • TP16
    see all
  • Cellular localizationCytoplasmic and Nuclear

References for Human CDKN2A/p16INK4a peptide (ab105631)

ab105631 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab105631.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"